Center for Drug Research, Chair of Pharmaceutical Biology (Prof. Angelika Vollmar)
«
With the help of Wimasis we can really do quantitative analysis of image-based angiogenesis assays
»
Prof. Dr. Stefan Zahler
Group Leader Angiogenesis
The Center for Drug Research covers all research areas around the development of novel drug – from chemical synthesis to innovative formulations. At the Chair of Pharmaceutical Biology (Prof. Dr. Angelika Vollmar) we investigate the pharmaceutical potential of natural compounds, be it of plant, animal or microbial origin.
Our main focus lies on tumor biology, with tumor angiogenesis (Prof. Dr. Stefan Zahler) as a central topic. Inhibiting the vessel growth in tumors in order to “starve” the malignancy is an old therapeutic concept, which has led to some clinical success, but still has its limits: due to evasive strategies of the tumors and to development of resistances we are still in need of novel therapeutic targets and inhibitors of angiogenesis. Therefore, not only try to get a better academic understanding of the angiogenesis process, but also screen novel inhibitors. More complex angiogenesis assays, like the tube formation assay, are image based and tedious to evaluate by hand.
Therefore they often are of limited use for screening purposes. The WimTube module overcomes this problem: it enables a robust rational evaluation of tube formation assays, and allows us to use this assay in a medium throughput screening approach.
In addition to the highly reproducible analysis, we also get valuable morphological information, which has to date not been used in classical evaluation routines.
case study
Technical University of Munich
«
Thanks to Wimasis we are now able to extract more information from every image we take
We have updated our Terms of Use and Privacy Policy to make our interaction with you and your personal data clearer as well as to comply with the new European General Data Protection Regulation (GDPR).
We have rewritten our Terms of Use to make them easier to read while covering the essential aspects of how your relationship with us works. Please take a look at them to check that there is no substantial change but a more defined interaction between us.
The updated Privacy Policy also explains more clearly and briefly how we use your personal information, without any change in our core commitment regarding your privacy.
As a requirement of the GDPR, we need you to accept both policies to keep providing you with service. If you have any questions or comments about them, please contact us and we will be glad to talk about them.
web developed with ❤ by Onimagin Technologies, Gavisa TIC and the help of these designers